Cambridge Nutritional Sciences plc (AIM: CNSL)
London
· Delayed Price · Currency is GBP · Price in GBX3.511
-0.039 (-1.10%)
Nov 20, 2024, 9:59 AM GMT+1
CNSL Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 8.97 | 9.77 | 7.55 | 8.54 | 6.82 | 9.82 | Upgrade
|
| Revenue Growth (YoY) | -0.80% | 29.53% | -11.63% | 25.28% | -30.58% | 12.13% | Upgrade
|
| Cost of Revenue | 3.32 | 3.73 | 4 | 3.44 | 2.82 | 3.52 | Upgrade
|
| Gross Profit | 5.66 | 6.05 | 3.55 | 5.1 | 4 | 6.29 | Upgrade
|
| Selling, General & Admin | 6.01 | 6.67 | 6.29 | 5.69 | 4.62 | 6.87 | Upgrade
|
| Other Operating Expenses | -0.06 | -0.08 | -0.03 | - | -0.15 | -0.26 | Upgrade
|
| Operating Expenses | 5.95 | 6.58 | 6.26 | 5.69 | 4.46 | 6.61 | Upgrade
|
| Operating Income | -0.3 | -0.54 | -2.72 | -0.59 | -0.47 | -0.31 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | -0.01 | -0.02 | -0.08 | -0.25 | Upgrade
|
| Interest & Investment Income | 0.05 | 0.05 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.09 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -0.18 | -0.51 | -2.73 | -0.61 | -0.55 | -0.57 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -7.73 | Upgrade
|
| Other Unusual Items | -0.06 | -0.24 | -0.52 | -0.34 | - | - | Upgrade
|
| Pretax Income | -0.24 | -0.75 | -3.25 | -0.95 | -0.55 | -8.3 | Upgrade
|
| Income Tax Expense | -0.42 | -0.42 | -0.08 | 0.46 | -0.93 | -1.47 | Upgrade
|
| Earnings From Continuing Operations | 0.17 | -0.33 | -3.17 | -1.41 | 0.39 | -6.83 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -0.69 | -9.92 | -2.49 | - | Upgrade
|
| Net Income | 0.17 | -0.33 | -3.86 | -11.33 | -2.1 | -6.83 | Upgrade
|
| Net Income to Common | 0.17 | -0.33 | -3.86 | -11.33 | -2.1 | -6.83 | Upgrade
|
| Shares Outstanding (Basic) | 219 | 238 | 231 | 183 | 172 | 140 | Upgrade
|
| Shares Outstanding (Diluted) | 220 | 238 | 232 | 187 | 177 | 140 | Upgrade
|
| Shares Change (YoY) | -6.43% | 2.70% | 23.98% | 5.59% | 26.20% | 10.40% | Upgrade
|
| EPS (Basic) | 0.00 | -0.00 | -0.02 | -0.06 | -0.01 | -0.05 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.00 | -0.02 | -0.06 | -0.01 | -0.05 | Upgrade
|
| Free Cash Flow | 0.44 | 0.56 | -3.18 | -4.2 | -4.38 | 0.35 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.00 | -0.01 | -0.02 | -0.02 | 0.00 | Upgrade
|
| Gross Margin | 63.02% | 61.86% | 46.98% | 59.75% | 58.63% | 64.10% | Upgrade
|
| Operating Margin | -3.29% | -5.47% | -35.98% | -6.93% | -6.87% | -3.19% | Upgrade
|
| Profit Margin | 1.94% | -3.36% | -51.15% | -132.72% | -30.87% | -69.54% | Upgrade
|
| Free Cash Flow Margin | 4.91% | 5.72% | -42.10% | -49.15% | -64.32% | 3.52% | Upgrade
|
| EBITDA | -0.08 | -0.3 | -2.39 | -0.05 | -0.1 | 0.03 | Upgrade
|
| EBITDA Margin | -0.85% | -3.04% | -31.63% | -0.61% | -1.48% | 0.31% | Upgrade
|
| D&A For EBITDA | 0.22 | 0.24 | 0.33 | 0.54 | 0.37 | 0.34 | Upgrade
|
| EBIT | -0.3 | -0.54 | -2.72 | -0.59 | -0.47 | -0.31 | Upgrade
|
| EBIT Margin | -3.29% | -5.47% | -35.98% | -6.93% | -6.87% | -3.19% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.